PPIDT00058
Drug Information
| Name | Interferon beta-1b |
|---|---|
| Sequence | SYNLLGFLQRSSNFQSQKLLWQLNGRLEYCLKDRMNFDIPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRQDSSSTGWNETIVENLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINRLTGYLRN |
| DrugBank_ID | DB00068 |
| Type | biotech |
| Indication | Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease as well as to decrease the frequency of attacks. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Solution | Subcutaneous |
0.300 mg
|
| Injection, powder, for solution | Subcutaneous |
0.25 mg
|
| Injection, powder, for solution | Subcutaneous |
0.25 MG/ML
|
| Solution | Parenteral; Subcutaneous |
0.25 MG/ML
|
| Injection, powder, for solution | Subcutaneous |
0.3 mg/vial
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
0.25 mg
|
| Injection, powder, lyophilized, for solution; kit | Subcutaneous |
0.25 mg/1mL
|
| Kit | Subcutaneous |
0.25 mg/1mL
|
| Powder, for solution | Subcutaneous |
0.3 mg / vial
|
| Injection, powder, for solution | Subcutaneous |
250 MCG/ML
|
| Injection, powder, for solution | Subcutaneous |
250 ug/ml
|
| Injection, powder, lyophilized, for solution; kit | Subcutaneous |
0.25 mg/1.0mL
|
| Powder | Subcutaneous |
250 MCG
|
| Solution | Subcutaneous |
300.000 mcg
|
| Powder | Subcutaneous |
8 MIU/1vial
|
Target Information